Honegger A, Dull T J, Szapary D, Komoriya A, Kris R, Ullrich A, Schlessinger J
Rorer Biotechnology, Inc., King of Prussia, PA 19406.
EMBO J. 1988 Oct;7(10):3053-60. doi: 10.1002/j.1460-2075.1988.tb03170.x.
Epidermal growth factor (EGF)-receptor mutants in which individual autophosphorylation sites (Tyr1068, Tyr1148 or Tyr1173) have been replaced by phenylalanine residues were expressed in NIH-3T3 cells lacking endogenous EGF-receptors. Kinetic parameters of the kinase of wild-type and mutant receptors were compared. Both wild-type and mutant EGF-receptors had a Km(ATP) 1-3 microM for the autophosphorylation reaction, and a Km(ATP) of 3-7 microM for the phosphorylation of a peptide substrate. These are similar to the Km(ATP) values reported for EGF-receptor of A431 cells. A synthetic peptide representing the major in vitro autophosphorylation site Tyr1173 of the EGF-receptor (KGSTAENAEYLRV) was phosphorylated by wild-type receptor with a Km of 110-130 microM, and the peptide inhibited autophosphorylation with a Ki of 150 microM. Mutant EGF-receptors phosphorylated the peptide substrate with a Km of 70-100 microM. A similar decrease of Km (substrate) was obtained when the phosphorylation experiments were performed with the commonly applied substrates angiotensin II and a peptide derived from c-src. The Km of angiotensin II phosphorylation was reduced from 1100 microM for wild-type receptor to 890 microM for mutant receptor and for c-src peptide from 1010 microM to 770 microM respectively. The Vmax of the kinase was dependent on receptor concentration, but was not significantly affected by the mutation. Analogs of the Tyr1173 peptide in which the tyrosine residue was replaced by either a phenylalanine or an alanine residue also inhibited autophosphorylation with Ki of 650-750 microM. These analyses show that alterations of individual autophosphorylation sites do not have a major effect on kinase activity.(ABSTRACT TRUNCATED AT 250 WORDS)
将单个自身磷酸化位点(酪氨酸1068、酪氨酸1148或酪氨酸1173)被苯丙氨酸残基取代的表皮生长因子(EGF)受体突变体,在缺乏内源性EGF受体的NIH-3T3细胞中表达。比较了野生型和突变型受体激酶的动力学参数。野生型和突变型EGF受体自身磷酸化反应的Km(ATP)为1 - 3微摩尔,肽底物磷酸化的Km(ATP)为3 - 7微摩尔。这些与报道的A431细胞EGF受体的Km(ATP)值相似。代表EGF受体主要体外自身磷酸化位点酪氨酸1173的合成肽(KGSTAENAEYLRV),被野生型受体磷酸化,Km为110 - 130微摩尔,该肽抑制自身磷酸化的Ki为150微摩尔。突变型EGF受体磷酸化肽底物的Km为70 - 100微摩尔。当用常用底物血管紧张素II和源自c-src的肽进行磷酸化实验时,得到了类似的Km(底物)降低。血管紧张素II磷酸化的Km从野生型受体的1100微摩尔降至突变型受体的890微摩尔,c-src肽的Km分别从1010微摩尔降至770微摩尔。激酶的Vmax取决于受体浓度,但不受突变的显著影响。酪氨酸1173肽中酪氨酸残基被苯丙氨酸或丙氨酸残基取代的类似物也以650 - 750微摩尔的Ki抑制自身磷酸化。这些分析表明,单个自身磷酸化位点的改变对激酶活性没有主要影响。(摘要截断于250字)